cifenline has been researched along with Atrial Flutter in 13 studies
Atrial Flutter: Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
Excerpt | Relevance | Reference |
---|---|---|
"This multicentre, randomized, double-blind study, conducted in parallel groups, was designed to compare the efficacy and safety of cibenzoline (C) and oral propafenone (P) in the prevention of recurrent atrial arrhythmias (M) over a 6-month period." | 9.08 | [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. ( Bleinc, D; Canler, A; Lardoux, H; Maison Blanche, P; Marchand, X; Péraudeau, P; Rouesnel, P; Scheck, F, 1996) |
"This multicentre, randomized, double-blind study, conducted in parallel groups, was designed to compare the efficacy and safety of cibenzoline (C) and oral propafenone (P) in the prevention of recurrent atrial arrhythmias (M) over a 6-month period." | 5.08 | [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. ( Bleinc, D; Canler, A; Lardoux, H; Maison Blanche, P; Marchand, X; Péraudeau, P; Rouesnel, P; Scheck, F, 1996) |
" These antiarrhythmics, prescribed to prevent atrial fibrillation (3 patients) and atrial flutter (5 patients), were flecainide in 4 cases, propafenone in 2 cases and cibenzoline and hydroquinidine respectively associated with digitoxine and propranolol." | 4.79 | [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications]. ( Aouate, P; Benassar, A; Fontaine, G; Frank, R; Jacquemin, M; Laborde, JP; Tageddine, R; Tonet, J; Turlure, A, 1995) |
"Seventeen patients had documented recurrence of atrial arrhythmia (9 in the cibenzoline group, 8 in the flecainide group) during the study." | 2.68 | Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study. ( Babuty, D; D'Hautefeuille, B; Mycinsky, C; Peraudeau, P; Pruvost, P; Scheck, F, 1995) |
"In the not-responders, the mean time to recurrence was 75 +/- 48 days in group C and 75 +/- 62 days in group F(NS)." | 2.68 | [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias]. ( Babuty, D; Brembilla-Perrot, B; Breuillac, JC; Fauchier, JP; Funck, F; Garnier, LF; Maison-Blanche, P; Medvedowsky, JL; Peraudeau, P; Rouesnel, P; Scheck, F, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 9 (69.23) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brembilla-Perrot, B | 3 |
Houriez, P | 1 |
Claudon, O | 1 |
Yassine, M | 1 |
Suty-Selton, C | 1 |
Vancon, AC | 1 |
Abo el Makarem, Y | 1 |
Makarem, E | 1 |
Courtelour, JM | 1 |
Kawabata, M | 1 |
Hirao, K | 1 |
Higuchi, K | 1 |
Sasaki, T | 1 |
Furukawa, T | 1 |
Okada, H | 1 |
Hachiya, H | 1 |
Isobe, M | 1 |
Babuty, D | 2 |
D'Hautefeuille, B | 1 |
Scheck, F | 3 |
Mycinsky, C | 1 |
Pruvost, P | 1 |
Peraudeau, P | 3 |
Pisapia, A | 1 |
Bine-Scheck, F | 1 |
Schenowitz, A | 1 |
Domerego, JJ | 1 |
Maraud, L | 1 |
Canler, A | 2 |
Labban, N | 1 |
Viart, R | 1 |
Aubry, P | 1 |
Beruben, E | 1 |
Manz, M | 1 |
Lüderitz, B | 1 |
Andrivet, P | 1 |
Mach, V | 1 |
Gnoc, CV | 1 |
Aouate, P | 1 |
Frank, R | 1 |
Fontaine, G | 1 |
Tonet, J | 1 |
Tageddine, R | 1 |
Benassar, A | 1 |
Turlure, A | 1 |
Jacquemin, M | 1 |
Laborde, JP | 1 |
Lardoux, H | 1 |
Maison Blanche, P | 1 |
Marchand, X | 1 |
Rouesnel, P | 2 |
Bleinc, D | 1 |
Maison-Blanche, P | 1 |
Fauchier, JP | 1 |
Garnier, LF | 1 |
Breuillac, JC | 1 |
Funck, F | 1 |
Medvedowsky, JL | 2 |
Terrier de la Chaise, A | 1 |
Jacquemin, L | 1 |
Beurrier, D | 1 |
Houplon, P | 1 |
Louis, P | 1 |
Danchin, N | 1 |
Honda, T | 2 |
Soejima, H | 1 |
Kühlkamp, V | 1 |
Meerhof, J | 1 |
Schmidt, F | 1 |
Mayer, F | 1 |
Ickrath, O | 1 |
Haasis, R | 1 |
Seipel, L | 1 |
Frances, Y | 1 |
Luccioni, R | 1 |
Delaage, M | 1 |
Donnarel, G | 1 |
Quiret, JC | 1 |
2 reviews available for cifenline and Atrial Flutter
Article | Year |
---|---|
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Th | 1995 |
6 trials available for cifenline and Atrial Flutter
Article | Year |
---|---|
Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Toleran | 1995 |
[Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atr | 1994 |
[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation | 1996 |
[Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Flecainide; Humans | 1997 |
Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Respon | 2000 |
[Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; | 1985 |
5 other studies available for cifenline and Atrial Flutter
Article | Year |
---|---|
[Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Flutter; Female; Flecainide; Humans; Imi | 2000 |
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Case | 2008 |
A clinical study of intravenous cibenzoline in selected patients with recent-onset atrial tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Imidazoles; | 1993 |
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; | 1997 |
Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular | 1990 |